IE34648L - Pharmaceutical composition containing garcinia acid - Google Patents
Pharmaceutical composition containing garcinia acidInfo
- Publication number
- IE34648L IE34648L IE701367A IE136770A IE34648L IE 34648 L IE34648 L IE 34648L IE 701367 A IE701367 A IE 701367A IE 136770 A IE136770 A IE 136770A IE 34648 L IE34648 L IE 34648L
- Authority
- IE
- Ireland
- Prior art keywords
- garcinia acid
- pharmaceutical composition
- garcinia
- acid
- composition containing
- Prior art date
Links
- PFHZIWAVXDSFTB-UHFFFAOYSA-N hibiscusoic acid Natural products OC(=O)C1OC(=O)CC1(O)C(O)=O PFHZIWAVXDSFTB-UHFFFAOYSA-N 0.000 title abstract 8
- ZMJBYMUCKBYSCP-CVYQJGLWSA-N Garcinia acid Chemical compound OC(=O)[C@@H](O)[C@](O)(C(O)=O)CC(O)=O ZMJBYMUCKBYSCP-CVYQJGLWSA-N 0.000 title abstract 5
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- -1 garcinia acid lactone Chemical class 0.000 abstract 3
- 150000005690 diesters Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 101000653791 Bos taurus Protein S100-A12 Proteins 0.000 abstract 1
- 150000001447 alkali salts Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 150000005691 triesters Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1311015 Compositions comprising garcinia acid or derivatives thereof F HOFFMAN-LA ROCHE & CO AG 27 Oct 1970 [29 Oct 1969] 50982/70 Heading A5B A pharmaceutical composition comprises garcinia acid, a mono-, di- or tri-ester of garcinia acid, garcinia acid lactone, a diester of garcinia acid lactone, a non-toxic pharmaceutically acceptable basic salt of garcinia acid or garcinia acid lactone or esters thereof in admixture with a pharmaceutically acceptable carrier. The compositions may be made up in forms suitable for enteral or parenteral administration.
[GB1311015A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87241369A | 1969-10-29 | 1969-10-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE34648L true IE34648L (en) | 1971-04-29 |
| IE34648B1 IE34648B1 (en) | 1975-07-09 |
Family
ID=25359519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1367/70A IE34648B1 (en) | 1969-10-29 | 1970-10-26 | Pharmaceutical compositions and a process for the manufacture thereof |
Country Status (9)
| Country | Link |
|---|---|
| BE (1) | BE758122A (en) |
| CA (1) | CA923425A (en) |
| DE (1) | DE2052131A1 (en) |
| FR (1) | FR2070174B1 (en) |
| GB (1) | GB1311015A (en) |
| IE (1) | IE34648B1 (en) |
| IL (1) | IL35477A (en) |
| NL (1) | NL7015348A (en) |
| ZA (1) | ZA706931B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE792180A (en) * | 1971-12-02 | 1973-06-01 | Hoffmann La Roche | CITRIC ACID DERIVATIVES |
| FR2716374B1 (en) * | 1994-02-18 | 1996-04-19 | Sederma Sa | New cosmetic or dermopharmaceutical compositions containing plant extracts. |
| IT1276253B1 (en) * | 1995-12-15 | 1997-10-27 | Sigma Tau Ind Farmaceuti | PHARMACEUTICAL COMPOSITION CONTAINING L-CARNITINE OR ALCANOIL L-CARNITINE FOR THE PREVENTION AND TREATMENT OF SOFT STATES |
| ES2106689B1 (en) * | 1996-04-18 | 1998-05-16 | Cabo Soler Jose | NEW FORMULATION BASED ON HYDROXICITRIC ACID (SALTS AND DERIVATIVES) AND ITS COSMETIC AND PHARMACEUTICAL APPLICATIONS BY VIA TOPICA PERCUTANEA. |
| US20030004215A1 (en) * | 2001-06-15 | 2003-01-02 | Van Laere Katrien Maria Jozefa | Dietetic preparation and method for inhibiting intestinal carbohydrate absorption |
-
0
- BE BE758122D patent/BE758122A/en unknown
-
1970
- 1970-10-12 ZA ZA706931A patent/ZA706931B/en unknown
- 1970-10-19 IL IL35477A patent/IL35477A/en unknown
- 1970-10-20 NL NL7015348A patent/NL7015348A/xx not_active Application Discontinuation
- 1970-10-23 DE DE19702052131 patent/DE2052131A1/en active Pending
- 1970-10-26 IE IE1367/70A patent/IE34648B1/en unknown
- 1970-10-27 GB GB598270*[A patent/GB1311015A/en not_active Expired
- 1970-10-28 FR FR707038856A patent/FR2070174B1/fr not_active Expired
- 1970-10-29 CA CA096898A patent/CA923425A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL7015348A (en) | 1971-05-04 |
| ZA706931B (en) | 1971-07-28 |
| FR2070174B1 (en) | 1974-02-22 |
| GB1311015A (en) | 1973-03-21 |
| IE34648B1 (en) | 1975-07-09 |
| DE2052131A1 (en) | 1971-05-06 |
| CA923425A (en) | 1973-03-27 |
| BE758122A (en) | 1971-04-28 |
| FR2070174A1 (en) | 1971-09-10 |
| IL35477A0 (en) | 1970-12-24 |
| IL35477A (en) | 1973-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL35400A0 (en) | Furoyl and thenoylphenoxy acetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL50347A (en) | Heteroarylbenzoxepin acetic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them | |
| SE7501789L (en) | ||
| IE34648L (en) | Pharmaceutical composition containing garcinia acid | |
| GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
| GB1261989A (en) | 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same | |
| IL39885A0 (en) | Substituted xanthone carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL34255A0 (en) | ((thenylidene amino)oxy)alkyl carboxylic acids,their esters and salts,their preparation and pharmaceutical compositions containing them | |
| IL47103A0 (en) | 5-oxo-5h-dibenzo(a,d)-cycloheptene-2-acetic acid derivatives and salts and esters,their preparation and pharmaceutical compositions containing them | |
| IL37586A0 (en) | Indolylacetic acid derivatives and salts thereof,processes for their preparation and pharmaceutical compositions containing the same | |
| GB1327560A (en) | Effervescent pharmaceutical preparations | |
| CA960655A (en) | N(6)-aralkyl adenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
| GB1361779A (en) | Vincamine salt and its use as a pharmaceutical composition | |
| GB1290300A (en) | ||
| IE36255L (en) | Tripeptide | |
| IE35711B1 (en) | Pharmaceutical composition for inhibiting indoleamine-n-methyl transferase | |
| IE33519B1 (en) | Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process | |
| IL34769A (en) | Alpha-(4-isobutyl-1-cyclohexen-1-yl)-alkanoic acids and derivatives thereof,their preparation and pharmaceutical compositions containing them | |
| IL39888A (en) | Heterocyclic-substituted xanthone carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IE34386B1 (en) | Pharmaceutical compositions | |
| GB1294538A (en) | Pharmaceutical compositions | |
| GB1324568A (en) | Propionic acid and processes for its manufacture | |
| GB1417817A (en) | Substituted acetic acid cyclohexyl esters the preparation thereof and pharmaceutical compositions containing them | |
| IE36030L (en) | Anti-inflammatory preparations | |
| AU474109B2 (en) | Thiazole carboxylic acid derivatives, process forthe preparation thereof and pharmaceutical compositions containing same |